N-Benzoyl-L-leucine

Catalog No.: 
ACBKCV754
CAS No.: 
1466-83-7
Molecular Formula: 
C13H17NO3
Molecular Weight: 
235.28
N-Benzoyl-L-leucine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$90.00In stockIn stock
5g98%$409.00In stockIn stock
25g98%$1632.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Benzoyl-L-leucine
IUPAC Namebenzoyl-L-leucine
MDL No.MFCD00190766
Molecular FormulaC13H17NO3
Molecular Weight235.28
SMILESCC(C)C[C@@H](C(O)=O)NC(C1=CC=CC=C1)=O
InChI KeyPOLGZPYHEPOBFG-NSHDSACASA-N
SynonymCS-0201820 | AKOS010400584 | N-Benzoyl-L-leucine | benzoylleucine | N-Benzoyl-L-leucine, >=99.0% | BENZOYL-L-LEUCINE | HY-W142035 | L-Leucine, N-benzoyl- | POLGZPYHEPOBFG-NSHDSACASA-N | (S)-2-benzamido-4-methylpentanoic acid | DTXSID901316374 | Bz-Leu-OH
CAS No.1466-83-7
PubChem CID853887

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBKCV754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWFM015 route compound structure diagram
    ACCWFM015760-84-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBKCV754 route product structure diagram
    ACBKCV7541466-83-7In Stock
Inquiry

2. ACBKCV754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBKCV754 route product structure diagram
    ACBKCV7541466-83-7In Stock
Inquiry

3. ACBKCV754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBKCV754 route product structure diagram
    ACBKCV7541466-83-7In Stock
Inquiry

Comments (0)